{"id":303939,"date":"2019-11-11T18:00:17","date_gmt":"2019-11-12T02:00:17","guid":{"rendered":"https:\/\/nai500.com\/?p=303939"},"modified":"2019-11-11T23:33:33","modified_gmt":"2019-11-12T07:33:33","slug":"%e5%8c%bb%e7%96%97%e4%bf%9d%e5%81%a5%e6%96%b0%e9%97%bb%e7%b2%be%e9%80%89-3","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hans\/blog\/2019\/11\/%e5%8c%bb%e7%96%97%e4%bf%9d%e5%81%a5%e6%96%b0%e9%97%bb%e7%b2%be%e9%80%89-3\/","title":{"rendered":"\u533b\u7597\u4fdd\u5065\u65b0\u95fb\u7cbe\u9009"},"content":{"rendered":"<h4><strong>Welltower\u548c<\/strong><strong>Invesco<\/strong><strong>\u6210\u7acb8.5\u4ebf\u7f8e\u5143\u5408\u8d44\u4f01\u4e1a<\/strong><\/h4>\n<ul>\n<li><a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=WELL\">Welltower (NYSE:WELL)<\/a>\u548cInvesco (NYSE:IVZ)\u623f\u5730\u4ea7\u516c\u53f8\u6210\u7acb\u4e86\u4e00\u5bb6\u89c4\u6a21\u8fbe8.5\u4ebf\u7f8e\u5143\u7684\u5408\u8d44\u4f01\u4e1a\uff0c\u753135\u680b\u533b\u7597\u529e\u516c\u5927\u697c\u7ec4\u6210\uff0c\u603b\u9762\u79ef\u8fbe260\u4e07\u5e73\u65b9\u82f1\u5c3a\u3002<\/li>\n<li>\u8be5\u7269\u4e1a\u7ec4\u5408\u5148\u524d\u7531Welltower\u5168\u8d44\u62e5\u6709\u3002\u8fd9\u4e9b\u7269\u4e1a100%\u96b6\u5c5e\u4e8e\u536b\u751f\u7cfb\u7edf\uff0c\u52a0\u6743\u5e73\u5747\u79df\u8d41\u671f\u4e3a5\u5e74\u3002<\/li>\n<li>\u901a\u8fc7\u5408\u8d44\u4f01\u4e1a\uff0cWelltower\u5c06\u5728\u7269\u4e1a\u7ec4\u5408\u4e2d\u4fdd\u755915%\u7684\u7ecf\u6d4e\u6743\u76ca\u3002<\/li>\n<\/ul>\n<h4><strong>\u51cf\u91cd21%\uff0c\u7cd6\u5c3f\u75c5\u6cbb\u7597<\/strong><strong>\u5b9e\u73b0\u79ef\u6781\u6210\u6548<\/strong><\/h4>\n<ul>\n<li>\u4e00\u9879\u8bc4\u4f30<a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=NVS\">\u8bfa\u534e\uff08NYSE\uff1aNVS\uff09<\/a>bimagrumab\uff08\u4eba\u7c7b\u6297\u6fc0\u6d3b\u7d20\u53d7\u4f53\u5355\u514b\u9686\u6297\u4f53\uff09\u5728\u80a5\u80d6\u76842\u578b\u7cd6\u5c3f\u75c5\u60a3\u8005\u4e2d\u7684\u4e8c\u671f\u4e34\u5e8a\u8bd5\u9a8c\u663e\u793a\u51fa\u6cbb\u7597\u76ca\u5904\u3002<\/li>\n<li>\u5728\u7b2c48\u5468\uff0c\u63a5\u53d7bimagrumab\u6cbb\u7597\u7684\u60a3\u8005\u4f53\u5185\u8102\u80aa\u51cf\u5c11\u4e8621%\uff0c\u800c0.5%\u5b89\u6170\u5242\u7ec4\u4f53\u91cd\u51cf\u5c11\u4e866.5%\u3002<\/li>\n<li>\u8be5\u516c\u53f8\u4f7f\u7528MorphoSys\uff08NASDAQ\uff1aMOR\uff09\u4e13\u6709\u7684HuCAL\u6297\u4f53\u6280\u672f\u5f00\u53d1\u4e86\u8be5\u4ea7\u54c1\u3002\u5f00\u53d1\u6b63\u5728\u8fdb\u884c\u4e2d\u3002<\/li>\n<\/ul>\n<h4><strong>Reata<\/strong><strong>\u7684<\/strong><strong>bardoxolone<\/strong><strong>\u8fbe\u5230\u5b9e\u9a8c\u7ec8\u70b9<\/strong><\/h4>\n<ul>\n<li><a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=RETA\">Reata Pharmaceuticals(NASDAQ:RETA)<\/a>\u5ba3\u5e03\u4e86\u51762\/3\u671f\u4e34\u5e8a\u8bd5\u9a8cCARDINAL\u76843\u671f\u8bd5\u9a8c\u7684\u9633\u6027\u7ed3\u679c\uff0c\u8be5\u8bd5\u9a8c\u8bc4\u4f30\u4e86\u7532\u57fa\u5df4\u591a\u7d22\u9686\uff08bardoxolone\uff09\u7528\u4f5c\u6cbb\u7597\u7531\u7f55\u89c1\u7684\u9057\u4f20\u6027\u75be\u75c5\u201c\u5965\u5c14\u6ce2\u7279\u7efc\u5408\u5f81\u201d\u5f15\u8d77\u7684\u6162\u6027\u80be\u810f\u75be\u75c5\uff08CKD\uff09\u60a3\u8005\u3002<\/li>\n<li>\u4e0e\u5b89\u6170\u5242\u76f8\u6bd4\uff0c\u8fd9\u9879\u7814\u7a76\u8fbe\u5230\u4e86\u4ece\u57fa\u7ebf\u5230\u7b2c48\u5468\u5728\u7edf\u8ba1\u5b66\u4e0a\u6709\u6548\u589e\u52a0\u7684\u4e3b\u8981\u7ec8\u70b9\uff0c\u8fd9\u4e00\u6307\u6807\u88ab\u79f0\u4e3aeGFR\uff08\u4f30\u8ba1\u7684\u80be\u5c0f\u7403\u6ee4\u8fc7\u7387\uff09\u3002\u5173\u952e\u7684\u6b21\u8981\u7ec8\u70b9\u4e5f\u5f97\u5230\u4e86\u6ee1\u8db3\u3002<\/li>\n<li>\u636e\u8be5\u516c\u53f8\u79f0\uff0cFDA\u8868\u793a\u6cbb\u7597\u4e00\u5e74\u540e\uff0ceGFR\u7684\u6539\u5584\u53ef\u80fd\u8db3\u4ee5\u652f\u6301\u52a0\u901f\u6279\u51c6\u3002<\/li>\n<\/ul>\n<h4><strong>\u4ea7\u524d\u7b5b\u67e5\u6d4b\u8bd5\u51c6\u786e\u7387\u9ad8\uff0c<\/strong><strong>Myriad Genetics<\/strong><strong>\u80a1\u4ef7\u4e0a\u6da8<\/strong><strong>5<\/strong><strong>\uff05<\/strong><\/h4>\n<ul>\n<li>\u4e00\u9879\u65b0\u7684\u7814\u7a76\u7ed3\u679c\u53d1\u8868\u5728\u300a\u5987\u4ea7\u79d1\u8d85\u58f0\u300b\u4e0a\uff0c\u8868\u660e<a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=MYGN\">Myriad Genetics\uff08MYGN + 4.7%\uff09<\/a>\u65e0\u521b\u6027Prequel\u4ea7\u524d\u7b5b\u67e5\u6d4b\u8bd5\u7684\u51c6\u786e\u7387\u5f88\u9ad8\uff0c\u800c\u4e14\u6d4b\u8bd5\u5931\u8d25\u7387\u5f88\u4f4e\uff0c\u4ec5\u4e3a\u5343\u5206\u4e4b\u4e00\u3002<\/li>\n<li>Prequel\u4f7f\u7528\u5168\u57fa\u56e0\u7ec4\u6d4b\u5e8f\u6765\u9274\u5b9a\u67d3\u8272\u4f53\u5f02\u5e38\uff0c\u5305\u62ec13-\u4e09\u4f53\u7efc\u5408\u5f81\uff08\u4e0e\u667a\u529b\u548c\u8eab\u4f53\u6b8b\u75be\u6709\u5173\uff09\uff0c18-\u4e09\u4f53\u7efc\u5408\u5f81\uff08\u53d1\u80b2\u7f13\u6162\u548c\u8eab\u4f53\u7f3a\u9677\uff09\u548c21\uff08\u5510\u6c0f\u7efc\u5408\u75c7\uff09\u3002<\/li>\n<li>\u4ea7\u524d\u68c0\u6d4b\u51e0\u4e4e\u5360FQ1\u5206\u5b50\u8bca\u65ad\u68c0\u6d4b\u6536\u5165\u768414%\uff08$2350\u4e07\/1.72\u4ebf\uff09\u3002<\/li>\n<\/ul>\n<h4><strong>Galectin<\/strong><strong>\u4e0e\u897f\u95e8\u5b50\u5408\u4f5c\uff0c\u80a1\u4ef7\u4e0a\u6da8<\/strong><strong>8%<\/strong><\/h4>\n<ul>\n<li>\u7531\u4e8e\u4e0e\u897f\u95e8\u5b50\u533b\u7597\u4fdd\u5065\u516c\u53f8\u5408\u4f5c\uff0c<a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=GALT\">Galectin Therapeutics (GALT\u00a0+8.1%)<\/a>\u8fd1\u671f\u80a1\u4ef7\u589e\u957f\u4e86\u4e09\u500d\u4ee5\u4e0a\uff0c\u8fd9\u4f7f\u897f\u95e8\u5b50\u53ef\u4ee5\u4f7f\u7528GALT\u7684\u7b2c\u4e8c\u9636\u6bb5NASH-CX\u7814\u7a76\u6570\u636e\u6765\u652f\u6301\u5176ADVIA\u534a\u4eba\u9a6c\u809d\u7ea4\u7ef4\u5316\uff08ELF\uff09\u7684\u76d1\u7ba1\u5907\u6848\u3002<\/li>\n<li>\u8be5\u5408\u4f5c\u4f7f\u897f\u95e8\u5b50\u80fd\u591f\u4eceGALT\u8ba1\u5212\u4e2d\u76843\u671fNASH-RX\u7814\u7a76\u4e2d\u83b7\u5f97\u672a\u6765\u7684\u4e34\u5e8a\u548cADVIA\u534a\u4eba\u9a6c\u809d\u7ea4\u7ef4\u5316\uff08ELF\uff09\u6d4b\u8bd5\u6570\u636e\uff0c\u4ee5\u8bc4\u4f30\u65e0\u98df\u7ba1\u9759\u8109\u66f2\u5f20\u7684\u975e\u9152\u7cbe\u6027\u8102\u80aa\u6027\u809d\u708e\uff08NASH\uff09\u809d\u786c\u5316\u60a3\u8005\u7684belapectin\uff08GR-MD-02\uff09\u3002<\/li>\n<li>ADVIA ELF\u6d4b\u8bd5\u4f7f\u7528\u4e00\u79cd\u7b97\u6cd5\u6765\u5206\u6790\u4e09\u79cd\u8840\u6e05\u751f\u7269\u6807\u5fd7\u7269\u7684\u7ed3\u679c\uff0c\u5f97\u51fa\u65e8\u5728\u6539\u5584\u5bf9\u975e\u9152\u7cbe\u6027\u8102\u80aa\u6027\u809d\u75c5\/\u975e\u9152\u7cbe\u6027\u8102\u80aa\u6027\u809d\u708e\u548c\u5904\u4e8e\u75be\u75c5\u8fdb\u5c55\u98ce\u9669\u4e2d\u7684\u6162\u6027\u809d\u75c5\u60a3\u8005\u7684\u9884\u6d4b\u8bc4\u5206\u3002<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Welltower (NYSE:WELL) and Invesco (NYSE:IVZ) Real Estate form an $850M joint venture consisting of 35 medical office buildings adding up to 2.6M square feet.<\/p>\n","protected":false},"author":9,"featured_media":303941,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[427],"tags":[455,925,459],"class_list":["post-303939","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market-news-zh-hans","tag-455","tag-925","tag-459","sectors-life-science-zh-hans","locations-us-zh-hans","exchange-nasdaq-zh-hans","exchange-nyse-zh-hans"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/303939","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/comments?post=303939"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/303939\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media\/303941"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media?parent=303939"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/categories?post=303939"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/tags?post=303939"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}